A dominant activating RAC2 variant associated with immunodeficiency and pulmonary disease
Bas M. Smits(Wilhelmina Children's Hospital), Marianne Boes(University Medical Center Utrecht), Mariëlle van Gijn, Leo Koenderman(University Medical Center Utrecht), Marc van Dijk(Vrije Universiteit Amsterdam), Marjolein Turkenburg(Amsterdam University Medical Centers), Francesca A. Ververs(Boston Children's Hospital), Caroline A. Lindemans(University Medical Center Utrecht), Hans R. Waterham(Amsterdam University Medical Centers), P.H.C. Lelieveld(University Medical Center Utrecht), Lisette van de Corput(Heidelberg University), Joris van Montfrans(University Medical Center Utrecht), Stefan Nierkens(Utrecht University), Helen L. Leavis(University Medical Center Utrecht), Coco de Koning(University Medical Center Utrecht), Jaap Jan Boelens(Wilhelmina Children's Hospital), A C Bloem(University Medical Center Utrecht), Daan P. Geerke(Vrije Universiteit Amsterdam)
Cited by 28
Related Papers
Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells
|Nature|2007|844
Gut microbiome–derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease
|Nature Immunology|2016|727
Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis
|Blood|2016|554
Update on Neutrophil Function in Severe Inflammation
|Frontiers in Immunology|2018|420